K Wagner

发表

Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secondary progressive multiple sclerosis.

G J Barker, G. Barker, D. MacManus, 1999, Annals of neurology.

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis

F Barkhof, F. Barkhof, D. Knol, 2008, Multiple sclerosis.

MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN β-1b

M Filippi, M. Filippi, L. Kappos, 2003, Neurology.

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

G J Barker, A J Thompson, F Barkhof, 2000, Brain : a journal of neurology.